rs17207902

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001365276.2(TNXB):​c.7297G>A​(p.Val2433Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00256 in 1,613,170 control chromosomes in the GnomAD database, including 19 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. V2433V) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0057 ( 7 hom., cov: 32)
Exomes 𝑓: 0.0022 ( 12 hom. )

Consequence

TNXB
NM_001365276.2 missense

Scores

17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.537

Publications

3 publications found
Variant links:
Genes affected
TNXB (HGNC:11976): (tenascin XB) This gene encodes a member of the tenascin family of extracellular matrix glycoproteins. The tenascins have anti-adhesive effects, as opposed to fibronectin which is adhesive. This protein is thought to function in matrix maturation during wound healing, and its deficiency has been associated with the connective tissue disorder Ehlers-Danlos syndrome. This gene localizes to the major histocompatibility complex (MHC) class III region on chromosome 6. It is one of four genes in this cluster which have been duplicated. The duplicated copy of this gene is incomplete and is a pseudogene which is transcribed but does not encode a protein. The structure of this gene is unusual in that it overlaps the CREBL1 and CYP21A2 genes at its 5' and 3' ends, respectively. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
TNXB Gene-Disease associations (from GenCC):
  • Ehlers-Danlos syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • Ehlers-Danlos syndrome due to tenascin-X deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Illumina, PanelApp Australia, Orphanet
  • familial vesicoureteral reflux
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • vesicoureteral reflux 8
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0051888227).
BP6
Variant 6-32061592-C-T is Benign according to our data. Variant chr6-32061592-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 261157.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00569 (866/152206) while in subpopulation AFR AF = 0.0163 (678/41512). AF 95% confidence interval is 0.0153. There are 7 homozygotes in GnomAd4. There are 395 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 7 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TNXBNM_001365276.2 linkc.7297G>A p.Val2433Ile missense_variant Exon 21 of 44 ENST00000644971.2 NP_001352205.1
TNXBNM_001428335.1 linkc.8038G>A p.Val2680Ile missense_variant Exon 22 of 45 NP_001415264.1
TNXBNM_019105.8 linkc.7297G>A p.Val2433Ile missense_variant Exon 21 of 44 NP_061978.6 P22105-1O95680Q9Y464O95681

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TNXBENST00000644971.2 linkc.7297G>A p.Val2433Ile missense_variant Exon 21 of 44 NM_001365276.2 ENSP00000496448.1 P22105-3
TNXBENST00000647633.1 linkc.8038G>A p.Val2680Ile missense_variant Exon 22 of 45 ENSP00000497649.1 A0A3B3ISX9
TNXBENST00000375244.7 linkc.7297G>A p.Val2433Ile missense_variant Exon 21 of 44 5 ENSP00000364393.3 P22105-3

Frequencies

GnomAD3 genomes
AF:
0.00566
AC:
861
AN:
152088
Hom.:
7
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0163
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00400
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000189
Gnomad MID
AF:
0.00318
Gnomad NFE
AF:
0.00168
Gnomad OTH
AF:
0.00478
GnomAD2 exomes
AF:
0.00219
AC:
537
AN:
245738
AF XY:
0.00197
show subpopulations
Gnomad AFR exome
AF:
0.0176
Gnomad AMR exome
AF:
0.00206
Gnomad ASJ exome
AF:
0.000201
Gnomad EAS exome
AF:
0.0000558
Gnomad FIN exome
AF:
0.000279
Gnomad NFE exome
AF:
0.00170
Gnomad OTH exome
AF:
0.00150
GnomAD4 exome
AF:
0.00223
AC:
3265
AN:
1460964
Hom.:
12
Cov.:
122
AF XY:
0.00217
AC XY:
1579
AN XY:
726764
show subpopulations
African (AFR)
AF:
0.0142
AC:
474
AN:
33474
American (AMR)
AF:
0.00246
AC:
110
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.000153
AC:
4
AN:
26134
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39700
South Asian (SAS)
AF:
0.000186
AC:
16
AN:
86246
European-Finnish (FIN)
AF:
0.000303
AC:
16
AN:
52814
Middle Eastern (MID)
AF:
0.00123
AC:
7
AN:
5668
European-Non Finnish (NFE)
AF:
0.00225
AC:
2502
AN:
1111864
Other (OTH)
AF:
0.00222
AC:
134
AN:
60340
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
243
486
730
973
1216
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
114
228
342
456
570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00569
AC:
866
AN:
152206
Hom.:
7
Cov.:
32
AF XY:
0.00531
AC XY:
395
AN XY:
74418
show subpopulations
African (AFR)
AF:
0.0163
AC:
678
AN:
41512
American (AMR)
AF:
0.00399
AC:
61
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
0.000189
AC:
2
AN:
10600
Middle Eastern (MID)
AF:
0.00342
AC:
1
AN:
292
European-Non Finnish (NFE)
AF:
0.00168
AC:
114
AN:
68018
Other (OTH)
AF:
0.00473
AC:
10
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
38
75
113
150
188
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00228
Hom.:
1
Bravo
AF:
0.00660
ESP6500AA
AF:
0.0186
AC:
42
ESP6500EA
AF:
0.00162
AC:
8
ExAC
AF:
0.00252
AC:
302
EpiCase
AF:
0.00158
EpiControl
AF:
0.00166

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Oct 06, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 10, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Ehlers-Danlos syndrome Benign:1
Dec 04, 2020
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Ehlers-Danlos syndrome due to tenascin-X deficiency;C4014831:Vesicoureteral reflux 8 Benign:1
Jul 07, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cardiovascular phenotype Benign:1
Jul 05, 2019
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.080
BayesDel_addAF
Benign
-0.60
T
BayesDel_noAF
Benign
-0.62
CADD
Benign
11
DANN
Benign
0.95
DEOGEN2
Benign
0.028
T;.;T;T
Eigen
Benign
-0.86
Eigen_PC
Benign
-0.90
FATHMM_MKL
Benign
0.032
N
LIST_S2
Benign
0.65
.;T;T;T
MetaRNN
Benign
0.0052
T;T;T;T
MetaSVM
Benign
-1.0
T
PhyloP100
-0.54
PrimateAI
Benign
0.35
T
PROVEAN
Benign
-0.52
.;.;N;.
REVEL
Benign
0.029
Sift
Benign
0.11
.;.;T;.
Sift4G
Benign
0.37
.;.;T;T
Vest4
0.10
MVP
0.068
ClinPred
0.0013
T
GERP RS
1.1
Varity_R
0.054
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17207902; hg19: chr6-32029369; API